Market Analysis and Insights: Folate Deficiency Anemia Drug Market
Global Folate Deficiency Anemia Drug Market By Type (Dietary Folate Deficiency Anemia, Drug-Induced Folate Deficiency Anemia, Unspecified Folate Deficiency Anemia and Others), Treatment Type (Medication and Dietary Supplements), Drug Type (Vitamin B12 Injections and Iron Deficiency Replacement Drugs), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026
Global folate deficiency anemia drug market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Government policies and initiatives to offer a fund to many research institute and pharmaceuticals companies for developing novel therapy and emergence of drugs used in the treatment of Crohn’s disease, celiac disease, certain types of cancer and kidney problem that required dialysis as these can cause folate deficiencies are the key factors for the growth of this market
If you are an investor/shareholder in Folate Deficiency Anemia Drug Market, the provided study will help you to understand the growth model of Folate Deficiency Anemia Drug Market after the impact of COVID-19. Request for sample report@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...
Market Definition: Global Folate Deficiency Anemia Drug Market
Folate deficiency anemia is also knowns as Vitamin B9 deficiency anemia. It occurs when lack of lack of vitamin B12 causes the body to produce insufficient or abnormally large red blood cells which ultimately affects the body to be functional. Folate plays an important in the synthesis of genetic material like DNA, RNA and proteins. This deficiency may defacement cell division and an accumulation of possibly toxic metabolites, e.g. homocysteine. It is also important for re regulating the manufacture of red blood cells. It is most commonly found in pregnant and lactating women.
According to the article published in the National Health Services, it is estimated 1 in every 20 people aged 65 to 74 years old and 1 in every 10 people aged 75 or over are living with both vitamin B12 deficiency and folate deficiency anemia. This growing prevalence of folate deficiency anemia worldwide and vulnerable lactating women population are the key factors for the growth of this market.
Market Drivers
• Prevalence of inflammatory bowel disease worldwide acts as a driver for this market
• Increase cases of kidney disorders where dialysis is predominant treatment also enhances the market growth
• Increase in the rate of research and development initiatives is driving folate deficiency anemia therapeutics market
• Strategic alliance between the companies to increase the availability of the products is also driving the market growth
Market Restraints
• Inadequate knowledge about folate deficiency anemia in some developing countries acts as a restraint for the market
• Scientific and major technical challenges for production of disease specific novel therapies is hampering the market growth
• Patent expiry from many companies and introduction of generic drugs of branded version is expected to limit the growth of the market
Inquire before the purchasing report –@https://www.databridgemarketresearch.com/inquire-before-buying/?dbm...
Segmentation: Global Folate Deficiency Anemia Drug Market
By Type
• Dietary Folate Deficiency Anemia
• Drug-Induced Folate Deficiency Anemia
• Unspecified Folate Deficiency Anemia
• Others
By Treatment Type
• Medication
• Dietary Supplements
By Drug Type
• Vitamin B12 Injections
o Hydroxocobalamin
o Cyanocobalamin
• Iron Deficiency Replacement Drugs
o Ferric Carboxymaltose
o Iron Sucrose
o Iron Polymaltose
o Folic Acid
o L-Methylfolate
By Route of Administration
• Oral
• Injectable
By End-Users
•
o Hospitals
o Homecare
o Specialty Clinics
o Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• South America
o Brazil
o Rest of South America
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Turkey
o Belgium
o Netherlands
o Switzerland
o Rest of Europe
• Asia-Pacific
o Japan
o China
o South Korea
o India
o Australia
o Singapore
o Thailand
o Malaysia
o Indonesia
o Philippines
o Rest of Asia Pacific
• Middle East & Africa
o South Africa
o Rest of Middle East & Africa
Key Developments in the Market:
In April 2019, Merck KGaA has launched Arcofolin, a monosodium salt of L-5-methyltetrahydrofolic acid for the treatment and prevention from the folate deficiencies. The launch of Arcofolin will give patients a new biologic form of vitamin B9 which is not only easy for the body to metabolize but also enhanced the water solubility and hence improved condition of folate deficiencies
In January 2015, Helsinn Healthcare SA In-licensed exclusive U.S. commercialization rights from PHARMACOSMOS A/S for Monofer, an intravenous iron replacement therapy to be developed for the treatment of iron deficiency anaemia. Under the deal terms, PHARMACOSMOS A/S to receive a payments of up to USD 130.00mm for Monofer and eligible to receive further payments for the manufacture and supply of Monofer to Helsinn Healthcare SA in the United States. These strategic alliances between the companies increase availability of the product for patients suffering from folate deficiency anaemia throughout the United States
Competitive Analysis:
Global folate deficiency anemia drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global folate deficiency anemia drug market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Get Detailed Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-folate-de...
Browse more related report to know about market analysis
• Asia-Pacific Anti-Nuclear Antibody Test Market
• Asia-Pacific Rx Dermatology Topical Drug Delivery Market
• Europe Anticoagulation Therapy Market
• Europe Dry Eye Syndrome Treatment Market
• Ameloblastic Carcinoma Market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact: Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]